phone icon (917) 310-3371 Book an Appointment Menu
close menu
Nao Medical Logo

Colorectal cancer screening without guesswork

Cologuard, colonoscopy planning, average-risk screening questions, and the next-step guidance people usually need before they wait too long.

Cologuard home screening
Colorectal cancer screening awareness
Primary care screening consult
The first decision is usually stool test vs colonoscopy Average-risk adults often want to know whether an at-home stool test is enough, when colonoscopy is the stronger next step, and what happens if a screening result comes back abnormal.

The main colorectal screening decisions

Most patients do not need more generic colon-cancer awareness copy. They need a cleaner explanation of when stool testing is reasonable and when colonoscopy should move to the front of the conversation.

Cologuard for average-risk adults

Cologuard is typically discussed for average-risk adults 45 and older who want a non-invasive at-home screening option and who do not already need colonoscopy now.

Read more

Colonoscopy when the risk profile changes

Symptoms, prior polyps, family history, inflammatory bowel disease, or a positive stool test can all push colonoscopy higher in the decision tree.

Follow-up after abnormal screening

The most important patient question after a positive stool-based result is what happens next and how quickly that follow-up needs to move.

What matters before you choose a colorectal screening path

The answer is rarely just preference. Risk level, symptoms, and screening history all matter.

When Cologuard usually comes up

Cologuard is usually a conversation for average-risk adults who want an at-home stool-DNA screening option and who are still in the stage of deciding how to start screening.

  • Often discussed for adults 45 and older at average risk.
  • Useful for patients prioritizing convenience and home collection.
  • Not the same thing as a colonoscopy replacement for every situation.

When colonoscopy tends to matter more

Colonoscopy becomes a much stronger next step when a patient has symptoms, a significant family history, prior polyps, certain high-risk conditions, or a positive stool-based result.

  • Symptoms are different from routine screening.
  • Higher-risk patients should not assume stool testing is enough.
  • Positive Cologuard results usually lead into colonoscopy follow-up.

What Nao can do in the middle of that decision

The visit can help determine whether a patient is still in the average-risk screening phase or already in a category where colonoscopy should be taken more seriously now.

  • Review age and prior screening history.
  • Surface higher-risk factors that change the plan.
  • Route the patient to the correct next step instead of a dead-end page.

What an abnormal result means

A positive stool-based result is not a diagnosis by itself. It is a sign the screening path has changed and the next conversation usually needs to happen around colonoscopy follow-up.

  • Abnormal does not automatically mean cancer.
  • It does mean follow-up should not be ignored.
  • This is where patients most often need real coordination.

The pages that matter most for colorectal screening

Use the live Cologuard page for the direct at-home route and primary care for broader screening planning or follow-up questions.

Primary care hub

Primary care is the right home for broader screening conversations, risk review, and next-step planning when the answer is not obvious.

Open page

Cancer screening hub

The broader hub ties colorectal screening into PSA, Pap smears, Galleri, and lung-screening decisions instead of isolating it.

Open page

Questions about Cologuard and colonoscopy

These are the colorectal-screening questions that most directly affect the first decision and the follow-up path.

Cologuard is generally used for average-risk adults 45 and older who do not already need colonoscopy because of symptoms or higher-risk history.
No. Cologuard can be a screening option for some average-risk adults, but colonoscopy is still the better path in many higher-risk or follow-up situations.
A positive stool-based result usually means the next step is colonoscopy follow-up and a more direct evaluation.
Yes. Nao offers a direct Cologuard pathway and can also help patients sort out whether a broader colorectal-screening conversation should happen first.
Yes. Rectal bleeding, unexplained bowel changes, weight loss, iron-deficiency anemia, or other symptoms usually mean the conversation is no longer just routine screening.
Yes. Family history can push colonoscopy higher in the decision tree because it changes risk.
Yes. Insurance can apply to the starting visit, but final coverage depends on the exact screening path, outside lab processing, and whether follow-up procedures are needed.
The value at Nao is helping patients get onto the correct colorectal-screening path and understand the follow-up route. Colonoscopy itself is a separate procedural step.
Prior polyps usually make the screening conversation more colonoscopy-focused rather than purely stool-test-focused.
That is exactly the kind of patient who often needs help understanding whether home screening is still reasonable or whether colonoscopy should move up immediately.

Related screening pages

These supporting pages cover the adjacent screening decisions patients often compare alongside colorectal screening.

Cancer screening hub

Start with the main cancer-screening page for colorectal, Galleri, cervical, PSA, and lung-screening planning across the Nao network.

Protected Cologuard page

Use the paid Cologuard page for the direct home-screening path and colorectal-screening booking flow.

Galleri test

Review multi-cancer early-detection planning, who usually asks about Galleri, and what it does not replace.

PSA screening

Handle prostate-screening timing, shared-decision questions, and PSA blood-test planning through primary care.

Lung cancer screening

Check low-dose CT eligibility, smoking-history thresholds, and how screening conversations can start locally.

Move colorectal screening out of the abstract

The most useful colorectal page is the one that helps patients stop stalling and get onto the right screening path now.